Get the free weekly contract digest
The new new contracts, who’s behind them, and what they mean — delivered to your inbox every week. No credit card, unsubscribe anytime.
New new contracts, summarized for you
No login, no app to check — it comes to you
See who's moving and how much in your market
Muscular Dystrophy Association and AFM-Téléthon Partner to Award $510,000 Research Grant for Mitochondrial Myopathies and ALS Treatments
Contract Type
partnership
Description
The Muscular Dystrophy Association (MDA) and AFM-Téléthon have announced the award of two cutting-edge research grants to accelerate the development of treatments for mitochondrial myopathies and amyotrophic lateral sclerosis (ALS). The grants will support groundbreaking research studies focused on understanding and addressing the underlying mechanisms of these diseases, with the aim of developing new and innovative treatments that can significantly improve patients’ lives.